Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia

Stroke

Volumn 26, Issue 9, 1995, Pages 1670-1675

  Linnik, Matthew D ^a   Zahos, Peter ^b   Geschwind, Michael D ^b   Federoff, Howard J ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

apoptosis; cerebral ischemia; genetics; herpes simplex; neuronal death

Indexed keywords

ONCOPROTEIN; TRIPHENYLTETRAZOLIUM; VIRUS VECTOR;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DEFECTIVE VIRUS; ESCHERICHIA COLI; HERPES SIMPLEX VIRUS 1; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0028981908     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.26.9.1670     Document Type: Article

References (50)

1. Choi D, Rothman S. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171-182.
2. Hall E, Braughler J. Central nervous system trauma and stroke, II: physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med. 1989; 6:303-313.
3. Goto K, Ishige A, Sekiguchi K, Iizuka S, Sugimoto A, Yuzurihara M, Aburada M, Hosoya E, Kogure K. Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res. 1990;534: 299-302.
4. Linnik M, Zobrist R, Hatfield M. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 1993;24:2002-2009.
5. Li Y, Chopp M, Zhang Z, Zaloga C, Niewenhuis L, Gautam S. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 1994;25: 849-856.
6. Heron A, Pollard H, Dessi F, Moreau J, Lasbennes F, Ben-Ari Y, Charriaut-Marlangue C. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain. J Neurochem. 1993;61:1973-1976.
7. MacManus J, Buchan A, Hill I, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett. 1993;164:89-92.
8. MacManus J, Hill I, Huang Z-G, Rasquinha I, Xue D, Buchan A. DNA damage consistent with apoptosis in transient focal ischemic neocortex. Neuroreport. 1994;5:493-496.
9. Crumrine R, Thomas A, Morgan P. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab. 1994;14:887-891.
10. Ellis R, Yuan J, Horvitz H. Mechanisms and functions of cell death. Annu Rev Cell Biol. 1991;7:663-698.
11. Oppenheim R. Cell death during development of the nervous system. Annu Rev Neurosci. 1991;14:453-501.
12. Johnson EJ, Deckwerth T. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci. 1993;16:31-46.
13. Kane D, Sarafian T, Anton R, Hahn H, Gralla E, Seiverstone V, Ord T, Bredesen D. BCl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262:1274-1277.
14. Zhong L, Kane D, Bredesen D. BCl-2 blocks glutamate toxicity in neural cell lines. Mol Brain Res. 1993;19:353-355.
15. Behl C, Hovey LI, Krajewski S, Schubert D, Reed J. Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem Biophys Res Commun. 1993;197:949-956.
16. Allsopp T, Wyatt S, Paterson H, Davies A. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor dependent neurons from apoptosis. Cell. 1993;73:295-307.
17. Martinou J, Dubois-Dauphin M, Staple J, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring death and experimental ischemia. Neuron. 1994;13:1017-1030.
18. Dobson A, Margolis TP, Sedarati F, Stevens J, Feldman LT. A latent, nonpathogenic HSV-1 derived vector stably expresses beta-galactosidase in mouse neurons. Neuron. 1990;5:353-360.
19. Federoff H, Geschwind M, Geller A, Kessler J. Expression of nerve growth factor in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci U S A. 1992;89:1636-1640.
20. Andersen J, Garber D, Meaney C, Breakefield X. Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter. Hum Gene Ther. 1992;3:487-499.
21. Huang Q, Vonsattel J-P, Schaffer P, Martuza R, Breakefield X, Difiglia M. Introduction of foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study. Exp Neurol. 1992;115:303-316.
22. Fink D, Sternberg L, Weber P, Mata M, Goins W, Glorioso J. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-1 mediated transfer. Hum Gene Ther. 1992;3:11-19.
23. Breakefield X, Huang O, Andersen J, Kramer M, Bebrin W, Davar G, Vos B, Garber D, Difiglia M, Coen D. Gene transfer into the nervous system using recombinant herpes virus vectors. In: Gage F, Christen Y, eds. Gene Transfer and Therapy in the Nervous System. Heidelberg, FRG: Springer-Verlag; 1992:45-48.
24. Palella T, Silverman L, Schroll C, Homa F, Levine M, Kelley W. Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. Mol Cell Biol. 1988;8:457-460.
25. Kaplitt MG, Pfauss JG, Kleopoulous SP, Hanlon BA, Rabkin SD, Pfaff DW. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol Cell Neurosci. 1991;2:320-330.
26. Ho D, Mocarski E, Sapoloski R. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci U S A. 1993;90: 3655-3659.
27. During M, Naegele J, O'Malley K, Geller A. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 1994;266:1399-1403.
28. Geller AI, Breakefield XO. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science. 1988;241:1667-1669.
29. Geschwind M, Kessler J, Geller A, Federoff H. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Mol Brain Res. 1994;24: 327-335.
30. Xu H, Federoff H, Maragos J, Parada L, Kessler J. Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev Biol. 1994;163:152-161.
31. NGFR defines high-affinity NGF binding. J Neurosci. 1993;13:941-951.
32. Bergold P, Cassaccia-Bonnefil P, Xiu-Liu Z, Federoff H. Transynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci U S A. 1993;90:6165-6169.
33. Geschwind M, Lu B, Federoff H. Viral transfection of intrinsic cells within the brain: expression of neurotrophic genes from HSV-1 vectors: modifying neuronal phenotype. In: Conn PM, ed. Providing Pharmacological Access to the Brain. Orlando, Fl: Academic Press, Inc; 1994:462-482.
34. Federoff H. Growth of replication defective herpes virus amplicon vectors and their use for gene transfer. In: Spector D, Goldman R, Lienwand L, eds. Cell Biology: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1995.
35. Johnson P, Miyanohara A, Levine F, Cahill T, Friedman T. Cytotoxicity of replication-defective mutant of herpes simplex virus type 1. J Virol. 1992;66:2952-2965.
36. Paterson T, Everett R. A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J Gen Virol. 1990;71:1775-1783.
37. Paxinos GT, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press; 1986.
38. Park C, Mendelow A, Graham D, McCulloch J, Teasdale G. Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischemia. Neuropathol Appl Neurobiol. 1988;14:289-298.
39. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral artery and the ipsilateral common carotid arteries. J Cereb Blood Flow Metab. 1988;8:474-485.
40. Chen S, Hsu C, Hogan E, Maricq H, Balentine J. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;4:738-743.
41. Casals-Hatem D, Louie D, Tanaka S, Reed J. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the bcl-2 oncoprotein. Biochem Biophys Acta. 1992;1132:109-113.
42. Chen-Levy Z, Nourse J, Cleary M. The bcl-2 candidate proto-oncogene product is a 24 kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t (14:18). Mol Cell Biol. 1989;9:701-710.
43. Hockenberry D, Nunez G, Milliman C, Schreiber R, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
44. Almemri E, Robertson N, Fernandez T, Croce C, Litwack G. Overexpressed full-length human Bcl-2 extends survival of baculovirus-infected SF9 insect cells. Proc Natl Acad Sci U S A. 1992;89: 7295-7299.
45. Jacobson M, Burne F, King M, Miyashita T, Reed J, Raff M. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 1993; 361:365-369.
46. Tanaka S, Saito K, Reed J. Structure-function analysis of the apoptosis suppressing bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated bcl-2 proteins. J Biol Chem. 1993;268:10920-10926.
47. Hockenberry D, Oltvai Z, Yin X-M, Milliman C, Korsmeyer S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
48. Zhong L-T, Sarafian T, Kane D, Charles A, Man S, Edwards R, Bredesen D. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 1993;90:4533-4537.
49. Sharkey J, Butcher S. Immunophillins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature. 1994;371: 336-339.
50. Volpe B, Wessel T, Mukherjee B, Federoff H. Temporal pattern of internucleosomal DNA fragmentation in the striatum and hippocampus after transient forebrain ischemia. Neurosci Lett. 1995; 186:157-160.